v3.26.1
Condensed Consolidated Statements of Equity (Deficit) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Mezzanine Equity at beginning of period (in shares) at Dec. 31, 2024 28,000.00001              
Mezzanine Equity at beginning of period at Dec. 31, 2024 $ 23,861              
Mezzanine Equity                
Conversion of convertible preferred stock (in shares) (7,000)              
Conversion of convertible preferred stock $ (7,000)              
Preferred stock accretion $ 2,269              
Mezzanine Equity at end of period (in shares) at Jun. 30, 2025 21,000.00001              
Mezzanine Equity at end of period at Jun. 30, 2025 $ 19,130              
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2024     89,861,035          
Stockholders' equity at beginning of period at Dec. 31, 2024   $ (7,731) $ 9 $ (5,445) $ 718,797 $ (27,455) $ (693,637)  
Stockholders' Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     1,020,102          
Shares issued in connection with equity incentive plans   1 $ 1          
Stock-based compensation expense and vesting of restricted stock units   2,353     2,353      
Conversion of convertible preferred stock (in shares)     3,784,688          
Conversion of convertible preferred stock   7,000     7,000      
Preferred stock accretion (2,269) (2,269)     (2,269)      
Other   (376)         (376)  
Other comprehensive income (loss)   252       252    
Net income (loss) $ (16,720) (16,720)         (16,720)  
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2025     94,665,825          
Stockholders' equity at end of period at Jun. 30, 2025   (17,490) $ 10 (5,445) 725,881 (27,203) (710,733)  
Mezzanine Equity at beginning of period (in shares) at Mar. 31, 2025 21,000.00001              
Mezzanine Equity at beginning of period at Mar. 31, 2025 $ 18,374              
Mezzanine Equity                
Preferred stock accretion $ 756              
Mezzanine Equity at end of period (in shares) at Jun. 30, 2025 21,000.00001              
Mezzanine Equity at end of period at Jun. 30, 2025 $ 19,130              
Common stock, shares outstanding at beginning of period (in shares) at Mar. 31, 2025     93,934,569          
Stockholders' equity at beginning of period at Mar. 31, 2025   (11,379) $ 9 (5,445) 724,971 (28,196) (702,718)  
Stockholders' Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     731,256          
Shares issued in connection with equity incentive plans   1 $ 1          
Stock-based compensation expense and vesting of restricted stock units   1,666     1,666      
Preferred stock accretion   (756)     (756)      
Other   (336)         (336)  
Other comprehensive income (loss)   993       993    
Net income (loss) $ (7,679) (7,679)         (7,679)  
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2025     94,665,825          
Stockholders' equity at end of period at Jun. 30, 2025   (17,490) $ 10 (5,445) 725,881 (27,203) (710,733)  
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2025 112,819,881   112,819,881          
Stockholders' equity at beginning of period at Dec. 31, 2025 $ 18,375 18,375 $ 11 (5,445) 757,441 (26,716) (706,916) $ 0
Stockholders' Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     5,005,363          
Stock-based compensation expense and vesting of restricted stock units 3,668 3,668     3,668      
Shares withheld for taxes in connection with vested restricted stock units (in shares)     (952,133)          
Shares withheld for taxes in connection with vested restricted stock units (1,828) (1,828)   (1,828)        
Repurchase of shares pursuant to the stock repurchase agreement (in shares)     (1,904,762)          
Repurchase of shares pursuant to a stock repurchase agreement (17,019) (17,019) $ (1) (2,000) (15,018)      
Preferred stock accretion 0              
Sale of common stock, net (in shares)     3,384,994          
Sale of common stock, net 5,289 5,289 $ 1   5,288      
Issuance and sale of noncontrolling equity interest (Note 9) 15,003 14,202     14,202     801
Noncontrolling interest capital contribution 2,402 2,402     2,402      
Other comprehensive income (loss) 731 731       731    
Net income (loss) $ (3,765) (3,765)         (3,765)  
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2026 118,353,343   118,353,343          
Stockholders' equity at end of period at Jun. 30, 2026 $ 22,856 22,055 $ 11 (9,273) 767,983 (25,985) (710,681) 801
Common stock, shares outstanding at beginning of period (in shares) at Mar. 31, 2026     115,398,590          
Stockholders' equity at beginning of period at Mar. 31, 2026 34,288 33,487 $ 12 (7,273) 777,751 (26,124) (710,879) 801
Stockholders' Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     2,864,272          
Stock-based compensation expense and vesting of restricted stock units 2,499 2,499     2,499      
Repurchase of shares pursuant to the stock repurchase agreement (in shares)     (1,904,762)          
Repurchase of shares pursuant to a stock repurchase agreement (17,019) (17,019) $ (1) (2,000) (15,018)      
Sale of common stock, net (in shares)     1,995,243          
Sale of common stock, net 2,751 2,751     2,751      
Other comprehensive income (loss) 139 139       139    
Net income (loss) $ 198 198         198  
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2026 118,353,343   118,353,343          
Stockholders' equity at end of period at Jun. 30, 2026 $ 22,856 $ 22,055 $ 11 $ (9,273) $ 767,983 $ (25,985) $ (710,681) $ 801